NAGE

Niagen Bioscience, Inc.

NasdaqAdd to watchlist

$3.21

+$0.00+0.00%

Delayed · 2026-08-24T20:00:00.000Z · marketstack

Aug 10, 2026$3.21

+$0.16+5.25%over 1M

Day range22% of range

$3.19$3.28

Session

Previous close: $3.21
Open: $3.20
Volume: 415.74K
Avg volume: -
Day high: $3.28
Day low: $3.19

Fundamentals

Visualize fundamentals and more

Market cap: 254.62M
P/E ratio: 15.92
EPS (TTM): $0.20
Dividend yield: -
Beta: -
Shares outstanding: 79.32M

Source SEC EDGAR · 9/10/2026

Risk factors, year on year

Item 1AMarch 2026 10-KMarch 2025as filed.

added: 24
dropped: 20
re-drafted: 25

Out of 160 passages in this year’s Item 1A.

New this year

• Our business could be negatively impacted by cyber security incidents or threats, which could lead to data breaches, material interruption to our operations, manufacturing or laboratory systems, clinical trials, and IT systems, and violations of statutory …

43 more passages, included withBespoke

Recent activity

Nov 14Pamir Ozan bought 6,685 sharesInsider tradingForm 4Chief Financial Officer, about $46k

1 more event, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Ask about Niagen Bioscience, Inc.

The assistant answers from what NAGE has actually filed: 16 annual reports filed with the SEC, 6 Form 4 filings from the last year and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from NAGE's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Niagen Bioscience, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Niagen Bioscience, Inc.

Separate the decisions from the paperwork
Every Form 4 NAGE insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Niagen Bioscience, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.